I agree, Reason Remdisivir is not approved is because its only 50% effective, I think the requirement is 70%, If RVVTF achieves 70% or higher then it will become the first approved COVID drug then $50 will be cheap.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.